Announce Date | 05/01/2025 |
EPS Normalized Actual | $1.17 (Beat by $0.17) |
EPS GAAP Actual | $1.17 (Beat by $0.17) |
Revenue Actual | $6.774B |
Revenue Surprise | Beat by $6774M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.94168 |
EPS GAAP Estimate | $1.94168 |
Revenue Estimate | $9.23918595B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 10.10157 | 7.62 | 9.29766 | 10.81442 | 1 |
Dec 2026 | 8.03737 | 9.58 | 5.49 | 10.6 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.97 | 0.97 | 6.774B | 42.37% | 6774M |
FQ4 2024 (Dec 2024) | 1.48 | 1.48 | 7.158B | -39.28% | 7158M |
FQ3 2024 (Sep 2024) | 0.72 | 0.72 | 0.973B | -1212.85% | 973M |
FQ2 2024 (Jun 2024) | 0.72 | 0.72 | 6.56B | -101.49% | 6560M |
FQ1 2024 (Mar 2024) | 1.78 | 1.78 | 3.904B | -182.97% | 3904M |
FQ4 2023 (Dec 2023) | 0 | 0 | 9.97B | -15.94% | 9970M |
FQ3 2023 (Sep 2023) | 0 | 0 | 12.774B | -14.31% | 12774M |
FQ2 2023 (Jun 2023) | 2.05 | 2.05 | 13.218B | -9.25% | 13218M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.94168
Consensus Revenue Estimates
9.23918595B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.54075 | -- | 2.49321 | 2.57191 | 6 |
FQ3 2027 (Sep 2027) | 2.18753 | -- | 2.1466 | 2.21436 | 3 |
FQ2 2027 (Jun 2027) | 2.359 | -- | 2.31486 | 2.38793 | 3 |
FQ1 2027 (Mar 2027) | 2.20848 | -- | 2.16716 | 2.23557 | 6 |
FQ4 2026 (Oct 2026) | 2.40525 | -- | 2.29361 | 2.50042 | 4 |
FQ3 2026 (Jul 2026) | 2.38545 | -- | 2.27472 | 2.47984 | 4 |
FQ2 2026 (Jun 2026) | 2.4109 | -- | 2.33117 | 2.49344 | 4 |
FQ1 2026 (Mar 2026) | 2.2696 | 57.26 | 2.19454 | 2.3473 | 4 |
FQ4 2025 (Oct 2025) | 1.8988 | 22.06 | 1.81066 | 1.97393 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.96B | -- | 0.95B | 0.97B | 1 |
FQ3 2027 (Sep 2027) | 0.97B | -- | 0.95B | 0.97B | 1 |
FQ2 2027 (Jun 2027) | 0.97B | -- | 0.95B | 0.98B | 1 |
FQ1 2027 (Mar 2027) | 0.97B | -- | 0.95B | 0.98B | 1 |
FQ4 2026 (Oct 2026) | 6.85B | -- | 6.61B | 7.06B | 1 |
FQ3 2026 (Jul 2026) | 7.89B | -- | 7.61B | 8.13B | 1 |
FQ2 2026 (Jun 2026) | 7.89B | -- | 7.69B | 8.1B | 1 |
FQ1 2026 (Mar 2026) | 5.64B | -20.19 | 5.49B | 5.78B | 1 |
FQ4 2025 (Oct 2025) | 10.3B | 30.5 | 9.93B | 10.61B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.97 | 0.97 | 100% | |
FQ4 2024 (Dec 2024) | 1.48 | 1.48 | 100% | |
FQ3 2024 (Sep 2024) | 0.72 | 0.72 | 100% | |
FQ2 2024 (Jun 2024) | 0.72 | 0.72 | 100% | |
FQ1 2024 (Mar 2024) | 1.78 | 1.78 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | 2.05 | 2.05 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $6.77B | $6774M | 100% |
FQ4 2024 (Dec 2024) | $0B | $7.16B | $7158M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.97B | $973M | 100% |
FQ2 2024 (Jun 2024) | $0B | $6.56B | $6560M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.9B | $3904M | 100% |
FQ4 2023 (Dec 2023) | $0B | $9.97B | $9970M | 100% |
FQ3 2023 (Sep 2023) | $0B | $12.77B | $12774M | 100% |
FQ2 2023 (Jun 2023) | $0B | $13.22B | $13218M | 100% |